505 related articles for article (PubMed ID: 28235465)
1. Ovarian reserve testing: a user's guide.
Tal R; Seifer DB
Am J Obstet Gynecol; 2017 Aug; 217(2):129-140. PubMed ID: 28235465
[TBL] [Abstract][Full Text] [Related]
2. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone.
Fleming R; Seifer DB; Frattarelli JL; Ruman J
Reprod Biomed Online; 2015 Oct; 31(4):486-96. PubMed ID: 26283017
[TBL] [Abstract][Full Text] [Related]
3. ACOG Committee Opinion No. 773 Summary: The Use of Antimüllerian Hormone in Women Not Seeking Fertility Care.
Obstet Gynecol; 2019 Apr; 133(4):840-841. PubMed ID: 30913192
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
5. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
6. Testing ovarian reserve in pre-menopausal women: why, whom and how?
Podfigurna A; Lukaszuk K; Czyzyk A; Kunicki M; Maciejewska-Jeske M; Jakiel G; Meczekalski B
Maturitas; 2018 Mar; 109():112-117. PubMed ID: 29292013
[TBL] [Abstract][Full Text] [Related]
7. ACOG Committee Opinion No. 773: The Use of Antimüllerian Hormone in Women Not Seeking Fertility Care.
Obstet Gynecol; 2019 Apr; 133(4):e274-e278. PubMed ID: 30913198
[TBL] [Abstract][Full Text] [Related]
8. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
[TBL] [Abstract][Full Text] [Related]
9. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
10. Advanced reproductive age and fertility.
Liu K; Case A;
J Obstet Gynaecol Can; 2011 Nov; 33(11):1165-1175. PubMed ID: 22082792
[TBL] [Abstract][Full Text] [Related]
11. [Does the serum AMH assay allow predicting reliably female fertility?].
Rolland AL; Dewailly D
Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
[TBL] [Abstract][Full Text] [Related]
12. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
[TBL] [Abstract][Full Text] [Related]
13. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone.
Toner JP; Seifer DB
Fertil Steril; 2013 Jun; 99(7):1825-30. PubMed ID: 23548941
[TBL] [Abstract][Full Text] [Related]
14. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.
Pastore LM; Christianson MS; Stelling J; Kearns WG; Segars JH
J Assist Reprod Genet; 2018 Jan; 35(1):17-23. PubMed ID: 28971280
[TBL] [Abstract][Full Text] [Related]
15. [Anti mullerian hormone (AMH)--is it a new reliable marker of the ovarian reserve? Its role in predicting the ovarian response in assisted reproductive technology (ART)].
Alshiek JA; Lessing JB; Amit A; Azem F
Harefuah; 2012 Jul; 151(7):416-20, 435. PubMed ID: 23002694
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness and indications of AMH assay in women].
Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D
Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664
[TBL] [Abstract][Full Text] [Related]
17. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
Nelson SM; Klein BM; Arce JC
Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of ovarian reserve in women with polycystic ovary syndrome.
Huddleston HG
Semin Reprod Med; 2013 Nov; 31(6):452-61. PubMed ID: 24101226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
